Glycan Arrays Lead to the Discovery of Autoimmunogenic Activity of SARS-CoV

Physiological Genomics - United States
doi 10.1152/physiolgenomics.00102.2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Discovery of a 382-Nt Deletion During the Early Evolution of SARS-CoV-2

2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

Inhibition of SARS-CoV 3c-Like Protease Activity by Theaflavin-3,3'-Digallate (TF3)

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2005English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Early Spread of SARS-Cov-2 in the Icelandic Population

2020English

Inhibition of SARS-CoV 3CL Protease by Flavonoids

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Discovery of Baicalin and Baicalein as Novel, Natural Product Inhibitors of SARS-CoV-2 3CL Protease in Vitro

2020English

The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2020English

On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy